Jun 5 |
The 3 Best Biotech Stocks to Buy in June 2024
|
May 31 |
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024
|
May 14 |
Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
|
May 8 |
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
|
May 7 |
Protagonist GAAP EPS of $3.26, revenue of $254.95M
|
May 7 |
Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital One 1st Annual Biotech/Biopharma Disruptors Event
|
May 7 |
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
Apr 29 |
We Might See A Profit From Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Soon
|
Apr 16 |
Turnstone Biologics Appoints William Waddill to its Board of Directors
|
Apr 5 |
All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy
|